Interferon Alpha Therapy Increases Pro-Thrombotic Biomarkers in Patients with Myeloproliferative Neoplasms

Myeloproliferative neoplasms (MPN) are associated with an increased risk of arterial and venous thrombosis. Pegylated-interferon alpha (IFN) and hydroxyurea (HU) are commonly used to treat MPN, but their effect on hemostasis has not yet been studied. The aim of our study was to determine whether IFN...

Descripción completa

Detalles Bibliográficos
Autores principales: Faille, Dorothée, Lamrani, Lamia, Loyau, Stéphane, Huisse, Marie-Geneviève, Bourrienne, Marie-Charlotte, Alkhaier, Sawsaneh, Cassinat, Bruno, Boulaftali, Yacine, Debus, Jérôme, Jandrot-Perrus, Martine, Chomienne, Christine, Dosquet, Christine, Ajzenberg, Nadine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226618/
https://www.ncbi.nlm.nih.gov/pubmed/32316612
http://dx.doi.org/10.3390/cancers12040992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226618/
https://www.ncbi.nlm.nih.gov/pubmed/32316612
http://dx.doi.org/10.3390/cancers12040992

Ejemplares similares